Amie Leighton is the CEO and Co-Founder of Allia Health, the first full-stack, AI-native clinical group for mental health, on a mission to make quality mental healthcare accessible to all by putting clinicians at the center of care.

Amie dropped out of Oxford University, where she served as head of healthcare at the M&A Group and conducted NERC-funded research at Imperial College London on hydrological systems for UK AID and the UN FAO, before declining a place at medical school to build Allia.

Amie brings a rare combination of research rigor, healthcare systems thinking, and entrepreneurial conviction, having walked away from both Oxford and a medical school offer to pursue a more scalable solution to the mental health crisis.

Allia Health is backed by Tim Draper and angel investors from Stanford Healthcare Innovation Labs, having raised a $2M Seed round, and is a Y Combinator-backed company with $50M+ in annualized national insurance contracts.

Allia has united 600+ clinicians across 70 locations in 32 states plus telehealth nationwide, delivering coordinated mental health care spanning therapy, psychiatry, primary care, and specialty services as one connected patient journey.